Keywords: fda, accepts, baxter, nda, icodextrin, new, drug

FDA accepts Baxter's NDA for icodextrin

Article | 19 February 2001

Print This

Baxter's New Drug Application for its peritoneal dialysis solutionicodextrin 7.5% has been accepted for review by the US Food and Drug ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in